Hyderabad, India -- (SBWIRE) -- 02/14/2018 -- The Global Lung Cancer Therapeutics Market was worth $5.65 billion in 2016 and estimated to be growing at a CAGR of 6.7%, to reach $7.81 billion by 2021. The rising proportion of smoking population and pollution are the key projected drivers behind the growth.

Introduction of scientifically advanced new treatments is also expected to drive forward the market growth globally. Invention of safer and novel could increase the scope of the market widely, and into still untapped markets around the world.

The availability of advanced radiation treatment facilities and superior priced drugs in the market in the future is supposed to increase the market share globally. In the present day, cigarette smoking is projected to be the key driver behind the increase in the occurrence of lung cancer, which subsequently increases the market share.

In the U.S., lung cancer is currently the most occurring cancer among the population, and is again reasoned with the rising proportion of smoking population. Various reimbursement schemes by governments also propel the market growth forward. Though, the availability of generic drugs at subsidised rates is predicted to constrain the growth of the market.

Browse full research report with TOC on " Lung Cancer Therapeutics Market by Treatment Type (Chemotherapy (Cisplatin, Taxol, Navelbine, Camptosar and Alimta), Radiotherapy (External Beam, Internal Beam and Systemic) and Other Drugs (Abraxane, Avastin, Crizotinib, Docetaxel and Gefitinib)) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)" at: http://www.MarketDataForecast.com/industry-analysis/beryllium-market

Market Data Forecast has segmented the global lung cancer therapeutics market on the basis of treatment type:

Treatment Type (Volume, Kilograms; Revenue, USD Thousands; 2016-2021)
Chemotherapy Radiotherapy Other Drugs

Further Key Findings From the Report Suggest:
Poor treatment facilities in the emerging and developing countries around the globe is a key restraint to the market growth.
North America and Europe lead the lung cancer therapeutics market globally, owing to the high occurrence of smoking population.
High treatment costs and adverse effects of radiation treatments also deter the growth of the market.
Asia-Pacific region to have a high growth rate due to the increasing pollution because of the presence of large number of developing countries and the subsequent industrialisation.

Browse related reports by Market Data Forecast:
Colorectal Cancer Market – https://www.marketdataforecast.com/market-reports/global-colorectal-cancer-market-612/

About Market Data Forecast
Being a familiar face to the Fortune 500 companies in the field of market research, Market Data Forecast provides its clientele with research material through syndicated reports, consult projects and industry newsletters across various domains and verticals. Our in-house research panel, comprises of industry experts, vertical/domain specialists, supported by a well-built research & data models that help in providing insights for making well-informed decisions. We have a well-established data gathering network across 100+ countries through tie-ups and collaboration's with the key personnel in value chains & local research organizations. Apart the excellent research services, we also boast of unique post-purchase services offering a 24*7 analyst support for the period of six months. Further, though a continuous feedback from our users, clients and experts, we keep on innovating ourselves in this field to support the organizations in the most efficient ways.

Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Email: abhishek@marketdataforecast.com
Web: https://www.marketdataforecast.com/